Skip to main content
  • FDA Panel Backs TriClip G4 TEER Device for Symptomatic, Severe TR

    The TriClip G4 transcatheter edge-to-edge repair (TEER) device received a strong endorsement Tuesday from a U.S. Food and Drug Administration (FDA) advisory panel.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details